Zhengye Biotechnology (NASDAQ:ZYBT) Shares Climb 4.5% – Here’s Why

Shares of Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) were up 4.5% during trading on Wednesday. The stock traded as high as $1.18 and last traded at $1.16. Approximately 31,408 shares were traded during mid-day trading, an increase of 22% from the average session volume of 25,650 shares. The stock had previously closed at $1.11.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Zhengye Biotechnology presently has a consensus rating of “Sell”.

Zhengye Biotechnology Price Performance

The company has a 50 day simple moving average of $1.54 and a 200-day simple moving average of $1.20.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a China-based biotechnology company focused on the research, development, manufacturing and sale of veterinary biological products. Through its operating subsidiaries, the company serves the animal-health market, with products intended to help prevent and control infectious diseases affecting livestock and poultry.

The company’s product portfolio primarily consists of animal vaccines and related veterinary biological products. Its offerings are designed for use by animal farms, veterinary institutions and other participants in China’s livestock and poultry industries.

Zhengye Biotechnology operates in China and is headquartered in Jilin Province.